Helus Pharma share price logo

Helus Pharma

NASDAQ: CYBN

$8.32

+0.14

(+1.71%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 2 Jan 2026

Helus Pharma Stock Performance

as on January 3, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $8.14
    $8.38
    downward going graph

    2.16%

    Downside

    0.72%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.50
    $9.12
    downward going graph

    33.89%

    Downside

    9.62%

    Upside

    downward going graph

Helus Pharma share price movements today

Previous Close
$8.18
Open
$8.27
Volume
874.9K
Day's Low - High
$8.14 - $8.38
52 Week Low - High
$5.50 - $9.12

Helus Pharma Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Helus Pharma Stock Fundamentals & Key Indicators

Check Helus Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Helus Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Helus Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$-NANA0.00%0.00%
StrongBuy$20.4B247.69%-22.7283.27%0.00%
StrongBuy$30.0B13.31%36.7379.72%0.00%
StrongBuy$132.8B184.64%30.2586.04%0.00%
Buy$82.9B35.95%19.2284.86%0.46%

Analyst Recommendation on Helus Pharma Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Helus Pharma. Average target price of $48.04

Helus Pharma Share Price Target

Get share price movements and forecasts by analysts on Helus Pharma.

What analysts predicted

82.68%UPSIDE

Target Price

$48.04

Current Price

$8.32

Analyzed by

7 Analysts

Target

$48.04

Helus Pharma target price $48.04, a slight upside of 82.68% compared to current price of $8.32. According to 7 analysts rating.

Helus Pharma Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
-
-
-
-
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-8
-22
-15
-10
-42
-7
-21
-24
-33
-42
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Helus Pharma Annual Profit & Loss

All numbers in Millions USD

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
0
-
-
-
-
Gross Profit
0
0
0
0
-
Operating Income
-
-
-
-
-
EBITDA
-
-
-
-
-
Interest Expense
-
-
-
-
-
Depreciation
-
-
-
-
-
Income Before Tax
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
Net Income
-25
-56
-29
-57
-78
Net Profit Margin
-3729.17%
0.00%
0.00%
0.00%
0.00%

Helus Pharma News & Key Events

  • img

    Today's Timeline - 30 December

    Wed, 02:03 AM

    -

    Cybin launches an at-the-market equity program to issue up to US$100 million in common shares for growth and working capital.

Insights on Helus Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, CYBN stock has moved up by 38.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 797.3% return, outperforming this stock by 835.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 153.5% return, outperforming this stock by 171.5%

About Helus Pharma

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.
OrganisationHelus Pharma

FAQs

What is Helus Pharma share price today?

Helus Pharma share price today is $8.32 as on at the close of the market. Helus Pharma share today touched a day high of $8.38 and a low of $8.14.

What is the 52 week high and 52 week low for Helus Pharma share?

Helus Pharma share touched a 52 week high of $9.12 on and a 52 week low of $5.50 on . Helus Pharma stock price today i.e. is closed at $8.32,which is 8.77% down from its 52 week high and 51.27% up from its 52 week low.

How to invest in Helus Pharma Stock (CYBN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Helus Pharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Helus Pharma Stock (CYBN) from India?

Indian investors can start investing in Helus Pharma (CYBN) shares with as little as ₹95.20999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.10 in Helus Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Helus Pharma share’s latest price of $8.32 as on January 3, 2026 at 2:29 am IST, you will get 1.2019 shares of Helus Pharma. Learn more about fractional shares .